Risk-Benefit Analysis and Personalized Treatment in Multiple Sclerosis: Basing Treatment Goals on the Latest Evidence

Format: Journal Supplement
Credit(s): 1.00 (60 min)
Release Date: Oct 10, 2018
Expiration Date: Oct 10, 2019
Credit Type(s):
  • CME / AMA PRA Category 1 Credit™

PROGRAM OVERVIEW

RELATED COURSES

This entry was posted in . Bookmark the permalink.

Follow Us :

Follow Us :

© 2021 Rockpointe Corporation

Privacy Policy

© 2021 Rockpointe Corporation

Privacy Policy